Cerner Co. (NASDAQ:CERN) Expected to Announce Earnings of $0.59 Per Share

Share on StockTwits

Equities analysts predict that Cerner Co. (NASDAQ:CERN) will report earnings of $0.59 per share for the current quarter, according to Zacks. Ten analysts have issued estimates for Cerner’s earnings, with the highest EPS estimate coming in at $0.60 and the lowest estimate coming in at $0.58. Cerner reported earnings per share of $0.57 during the same quarter last year, which would suggest a positive year-over-year growth rate of 3.5%. The company is scheduled to report its next earnings results on Thursday, October 24th.

According to Zacks, analysts expect that Cerner will report full year earnings of $2.43 per share for the current financial year, with EPS estimates ranging from $2.41 to $2.46. For the next year, analysts expect that the company will post earnings of $2.93 per share, with EPS estimates ranging from $2.82 to $3.06. Zacks’ earnings per share averages are a mean average based on a survey of sell-side analysts that that provide coverage for Cerner.

Cerner (NASDAQ:CERN) last issued its earnings results on Wednesday, July 24th. The company reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.02. Cerner had a net margin of 10.75% and a return on equity of 15.14%. The business had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.44 billion. During the same period in the previous year, the company earned $0.62 earnings per share. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year.

A number of brokerages have recently commented on CERN. Cantor Fitzgerald lifted their price target on shares of Cerner from $75.00 to $85.00 and gave the stock an “overweight” rating in a research note on Monday, July 8th. Argus upgraded shares of Cerner from a “hold” rating to a “buy” rating in a research note on Thursday, August 22nd. Piper Jaffray Companies lifted their price target on shares of Cerner from $74.00 to $80.00 and gave the stock an “overweight” rating in a research note on Thursday, July 25th. Morgan Stanley lifted their price target on shares of Cerner from $49.00 to $62.00 and gave the stock an “underweight” rating in a research note on Friday, August 23rd. Finally, Citigroup lifted their price target on shares of Cerner from $77.00 to $84.00 and gave the stock a “buy” rating in a research note on Thursday, July 25th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and eleven have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $74.73.

In related news, EVP John Peterzalek sold 27,484 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $72.11, for a total transaction of $1,981,871.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Julie L. Gerberding sold 7,928 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $71.82, for a total transaction of $569,388.96. The disclosure for this sale can be found here. Insiders have sold 344,268 shares of company stock valued at $23,243,010 over the last 90 days. 0.75% of the stock is currently owned by company insiders.

Several institutional investors and hedge funds have recently bought and sold shares of the business. Acropolis Investment Management LLC lifted its holdings in shares of Cerner by 2.0% in the second quarter. Acropolis Investment Management LLC now owns 7,494 shares of the company’s stock worth $549,000 after buying an additional 148 shares in the last quarter. Advisor Partners LLC lifted its holdings in shares of Cerner by 2.2% in the second quarter. Advisor Partners LLC now owns 7,061 shares of the company’s stock worth $518,000 after buying an additional 154 shares in the last quarter. Destination Wealth Management lifted its holdings in shares of Cerner by 3.7% in the second quarter. Destination Wealth Management now owns 5,208 shares of the company’s stock worth $382,000 after buying an additional 187 shares in the last quarter. Coastal Investment Advisors Inc. lifted its holdings in shares of Cerner by 16.3% in the second quarter. Coastal Investment Advisors Inc. now owns 1,426 shares of the company’s stock worth $104,000 after buying an additional 200 shares in the last quarter. Finally, Berman Capital Advisors LLC lifted its holdings in shares of Cerner by 115.3% in the second quarter. Berman Capital Advisors LLC now owns 381 shares of the company’s stock worth $27,000 after buying an additional 204 shares in the last quarter. Institutional investors and hedge funds own 82.66% of the company’s stock.

Shares of CERN stock traded down $0.09 during trading hours on Monday, reaching $67.76. The company had a trading volume of 885,837 shares, compared to its average volume of 2,390,813. The business has a fifty day moving average price of $70.02 and a 200-day moving average price of $67.07. Cerner has a one year low of $48.78 and a one year high of $76.47. The firm has a market cap of $21.65 billion, a PE ratio of 30.66, a price-to-earnings-growth ratio of 1.92 and a beta of 0.92. The company has a debt-to-equity ratio of 0.22, a quick ratio of 2.50 and a current ratio of 2.52.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 9th. Investors of record on Wednesday, September 25th will be given a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 24th. This represents a $0.72 annualized dividend and a yield of 1.06%. Cerner’s dividend payout ratio (DPR) is 32.58%.

About Cerner

Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Featured Article: Understanding the different types of bonds

Get a free copy of the Zacks research report on Cerner (CERN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.